Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Cellectar
3122
Cellectar
Technology
Biotechnology
Health Care
Medical
Pharmaceuticals
PDC Cancer Therapeutics and Diagnostics, Targeted Delivery of Oncologic Payloads, #MultipleMyeloma #ClinicalTrial #HemOnc
Suggest edits
Raised
$13.6M
Follow us
Also headquartered in Madison
Exact Sciences
American Family
Venture Investors
Propeller Health
Quest Diagnostics
EatStreet
Zuku
Redox
WARF
SHINE Medical Technologies
Companies in the same industry
SHYFT Analytics
Regeneron Pharmaceuticals
Ipsen
Amplyx Pharmaceuticals, Inc
Batu Biologics
Chantest
Sirnaomics Inc
AFFiRiS AG
Sartorius
Frontida BioPharm, Inc.
Alexa global traffic share
Overview
Funding
3
Add info
Acquired by
11 Apr 2011
Novelos Therapeutics
Latest funding
Show all
$617,500
Debt financing - 2014
Undisclosed amount
Post-IPO equity - 2011
Location
Madison
,
United States
Headquarters
Explore Madison
Xconomy
Doyenne, Epic, Cellectar, & More: This Week’s Wisconsin Watchlist
Health
Xconomy
Cellectar Biosciences Shutting Down Manufacturing Operations
Manufacturing
Health
Xconomy
Promega, Cellectar, Blockchain, & More: This Week’s WI Watchlist
Science
Health
Xconomy
Gener8tor, Shine, Cellectar, & More: This Week’s Wisconsin Watchlist
Health
Xconomy
Epic, Zuckerberg, Cellectar, & More: This Week’s Wisconsin Watchlist
Health
Xconomy
WARF, Cellectar Expand Licensing Agreement For Blood Cancer Drug
Legal
Health
Science
Xconomy
After Navigating Ups and Downs, Cellectar CEO Caruso Looks to Future
Health
Xconomy
Cellectar Awarded Another Cancer Drug Patent
Health
Legal
Xconomy
Cellectar Announces $8M Stock Offering, Sending Shares Lower
Earnings
Stock markets
